During the pandemic, the country has limited passports, allowing them only for family emergencies or some work travel
COVID-19 Vaccination Bests Natural Immunity for Cutting Death, Hospitalizations
However, natural immunity tied to lower incidence of new infection
Pediatric Mental Health Emergency Visits With Prolonged LOS Up During 2021
Pediatric mental health visits with length of stay >12 and >24 hours accounted for 20.9 and 7.3 percent of all visits
Next-Generation COVID-19 Vaccines are Needed
Despite the availability of safe and effective vaccines, the SARS-CoV-2 coronavirus continues to circulate across the globe as 2022 comes to an end.
The existing COVID-19 vaccines have had a profoundly positive effect during the pandemic, reducing hospitalization and related fatalities.
Problems with vaccine hesitancy present throughout the pandemic continue today, wrote researchers with the US Food and Drug Administration and Brown University.
Cancer Prevention Vaccination Schedule Simplified
Parents concerned about their children's risk of being diagnosed with certain cancers have an important vaccination decision to make next year. Should they follow new guidance published by the World Health Organization (WHO)?
Or adhere to the U.S. Centers for Disease Control and Prevention (CDC) current multi-step human papovavirus (HPV) vaccination schedule?
As of February 2022, the CDC recommends two doses of the 9-valent HPV vaccine for all adolescents at age 11 or 12.
TSA Tips For Travelers With Disabilities
When departing from Texas on a winter holiday, air travelers with disabilities or medical conditions and who use medical devices should not think of a Transportation Security Administration (TSA) checkpoint as a barrier to their vacation.
While all travelers must undergo screening at the Austin-Bergstrom International Airport TSA checkpoint, passengers and companions may consult a TSA officer about the best way to relieve any concerns during the screening process.
First Monoclonal Antibody to Treat COVID-19 Approved
The first monoclonal antibody (mAbs) to treat COVID-19 has joined a short list of U.S. Food and Drug Administration (FDA) approved antivirals.
Roche announced yesterday that the FDA had approved Actemra® (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult patients receiving systemic corticosteroids and requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.
First Approved Capsid Inhibitor-Based HIV Treatment Option
While the U.S. Food and Drug Administration (FDA) has yet to approve an HIV vaccine candidate, approvals have been granted for the treatment of HIV-1 infection in heavily treatment-experienced (HTE) adults with multi-drug resistant (MDR) HIV-1 infection.
Gilead Sciences, Inc. announced today that Sunlenca® (lenacapavir), in combination with other antiretrovirals, has been granted approval by the U.S. FDA for treating HIV-1 infection in HTE adults with MDR HIV-1 infection.
Sunlenca is now the first and only FDA Approved Capsid Inhibitor-Based HIV treatment option.
Children’s Firearm Injuries Up During the Pandemic
Significant increases seen among children who are Black, very young, and with public insurance
Life Expectancy Down to 76.4 Years in 2021
Age-specific deaths rates increased for all age groups 1 year and over; no significant change seen in infant mortality rates